Design of peptidomimetic delta opioid receptor antagonists using the message-address concept
about
Crystal structure of the µ-opioid receptor bound to a morphinan antagonistNovel delta opioid receptor agonists with oxazatricyclodecane structure.Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.Complementarity of delta opioid ligand pharmacophore and receptor models.Pyrrolo- and pyridomorphinans: non-selective opioid antagonists and delta opioid agonists/mu opioid partial agonists.Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand seriesOpioid receptor desensitization: mechanisms and its link to toleranceComparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjectsNaltrindole inhibits human multiple myeloma cell proliferation in vitro and in a murine xenograft model in vivo5'-halogenated analogs of oxymorphindole.Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.Molecular recognition of opioid receptor ligands.Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.Modeling and simulation of the human delta opioid receptor.Novel opioid peptide derived antagonists containing (2S)-2-methyl-3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid [(2S)-Mdcp].Discovery of novel triazole-based opioid receptor antagonists.A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems.Positron emission tomography radioligands for the opioid system.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review.Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.Opioid involvement in alcohol drinking.A κ Opioid Pharmacophore Becomes a Spinally Selective κ-δ Agonist When Modified with a Basic Extender Arm.3-Hydroxy-4-methoxyindolomorphinans as delta opioid selective ligandsModulation of the Interaction between a Peptide Ligand and a G Protein-Coupled Receptor by Halogen Atoms[6,7]-heterocycle-fused 14-hydroxymorphinan derivatives: design, synthesis, and opioid receptor activity.Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat.Synthesis, biology, NMR and conformation studies of the topographically constrained delta-opioid selective peptide analogs of [beta-iPrPhe(3)]deltorphin I.Delta Opioid Pharmacology in Relation to Alcohol Behaviors.Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinan Derivatives Based on the Message-Address Concept.Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography.2,3-Disubstituted indoles from olefins and hydrazines via tandem hydroformylation-Fischer indole synthesis and skeletal rearrangement.Microwave-Assisted Rapid One-Pot Synthesis of Fused and Non-Fused Indoles and 5-[18 F]Fluoroindoles from Phenylazocarboxylates.Synthesis and Crystal Structure of C1-Symmetric 3,3′-Bi(1,1′-dinaphthyl-camphopyrazole)
P2860
Q27678133-BA2A5633-CC42-4B00-94B2-D24FE8E8E3C5Q33636151-12DE12C2-0E7B-41E0-9CA7-1E635A177D75Q33881402-35EDC5E0-1B80-43A7-9E34-5F09DA138A2AQ33910432-B30160C4-8C3B-400C-A5E0-D2DA2A73C0A3Q33955128-B6760E5D-3CB3-4F4E-ABB6-1EEBAE4BA1A5Q34168561-09A56413-ECD3-464B-9335-AFEA3665CFF6Q34244966-8D44585E-7456-4364-ABD3-201D35942E0BQ34729984-CAE9F5EC-0257-4536-AE24-82AD4DD86535Q35607208-342FB8A4-89FC-4177-BC36-B16E7CCB5540Q35916280-A30CC7E1-9741-46D2-B993-E769AD9CA0B3Q36105355-57635D2A-F93D-42C6-8372-BC533B64695DQ36113994-F6987028-E78A-4F14-8F91-40A83387F3DDQ36225640-3BCDDF7C-3AF3-4BC1-93FE-C975534DB9ECQ36439154-94F6FE9F-F7B3-476E-951C-B99B017FA52CQ36508649-5D14FADC-F29A-40E7-9209-652451030AB7Q36519212-470A48F5-497A-474B-8D81-E032ADB8584DQ37071535-A8ED525E-2A18-433C-A36C-7B57BEA0F5D1Q37219823-872E6336-4743-4149-BC7B-D8FA19C43DDAQ37523119-0052DAEC-1541-4B8A-9EA8-326430621C5CQ38166974-4A69B635-B5C7-433F-8573-43C5552D59B7Q38217456-6C45DC37-7C0B-4A24-BD02-067CE399598CQ38417339-6F7D72A9-18AA-4F8F-8A3B-1DDC0E087E0AQ38909015-EFA6F296-CC77-4F61-848B-A44BD54C79EDQ40577734-B2255B94-090E-4A49-8908-A9CA92D2C729Q40682626-9E2C97B7-DB14-4127-9B10-0FA6DA53E70BQ41950216-299CF279-6870-4952-9EEC-8363F95DE752Q42221001-6208B789-9A65-4C1A-BA82-96CC6798319EQ43256896-6C2936C4-26EE-4192-98BC-9F832BB39990Q44335361-E8DC4855-3F05-48DF-A189-B59358921B07Q44335376-88AC2ED1-3C55-4A2F-8FDE-387BEDE9FEA1Q44338055-ABB9AA98-7114-4079-B06F-D4B7C5E8B0B4Q44341032-9E1459A0-AF4F-472E-A8C7-4A4BF4BE1FD3Q44349926-30BFB89A-D220-49B3-AE07-AF76EC64B16BQ44352755-C0E40364-DA43-4813-9CBE-904821F0AA2EQ46878470-5327CED2-D158-4035-856F-01BCACCAA446Q48303344-14B0652D-53D0-47AA-A709-16AE5012051CQ59125954-619FC550-10DA-455C-B487-B756B01A8875
P2860
Design of peptidomimetic delta opioid receptor antagonists using the message-address concept
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Design of peptidomimetic delta ...... ng the message-address concept
@ast
Design of peptidomimetic delta ...... ng the message-address concept
@en
Design of peptidomimetic delta ...... ng the message-address concept
@nl
type
label
Design of peptidomimetic delta ...... ng the message-address concept
@ast
Design of peptidomimetic delta ...... ng the message-address concept
@en
Design of peptidomimetic delta ...... ng the message-address concept
@nl
prefLabel
Design of peptidomimetic delta ...... ng the message-address concept
@ast
Design of peptidomimetic delta ...... ng the message-address concept
@en
Design of peptidomimetic delta ...... ng the message-address concept
@nl
P2093
P356
P1476
Design of peptidomimetic delta ...... ng the message-address concept
@en
P2093
A E Takemori
P S Portoghese
P304
P356
10.1021/JM00168A028
P407
P577
1990-06-01T00:00:00Z